Agency Links:   Home  Contact Us   Help   Site Map
Link to Homepage

Patient/Public Info  |  Regional Services  |  Health Professionals Info  |  About BCCA  |  Research  |  Donating

B2M

Reviewed: Monday, April 06, 2009

Beta2-microglobulin is a protein found on the surface of most nucleated cells and is in particularly high concentrations on the surface of lymphocytes. It can be detected in both serum and urine. Serum levels are a function of its rate of synthesis, release into the serum and its rate of clearance by the kidneys. B2M is frequently elevated in lymphoproliferative diseases such as multiple myeloma, B-cell lymphoma, and chronic lymphocytic leukemia.

It may also be elevated in cancers of the GI tract, cervix, lung and breast. Benign elevations may be seen in Crohn's Disease, AIDS lymphadenopathy, liver disease, renal disease, renal transplants and inflammatory diseases such as rheumatoid arthritis and SLE.

Beta2-microglobulin is a MEIA AxSYM assay. Samples are serum (preferred), plasma or urine (random or an aliquot of 24 hour urine collection). Urine samples can be analyzed if pre-arranged with the lab.

Reference Range:
serum = < 2 mg/L
urine = <0.13 µg/L

Interferences: HAMA.


The BC Cancer Agency is a part of the Provincial Health Services Authority .
If you notice a problem with this page, please report it via the Bug Report Form.
Copyright © 2010. BC Cancer Agency. All Rights Reserved. | Terms of Use | Privacy

Unofficial document if printed. Please refer to the following web address for up-to-date information: http://www.bccancer.bc.ca/HPI/CancerManagementGuidelines/TumourMarkers/B2M.htm